Sarah-Anne Nicholas: Excited to Share My First-Author Publication from My PhD Research
Sarah-Anne Nicholas, Post Doctoral Fellow at Boehringer Ingelheim, shared a post on LinkedIn, about a recent article she and her colleagues co-authored, published in AHA Journals:
“Excited to share my first-author publication featuring research from my PhD.
It feels amazing to see this work out in the world, especially because it supports a shift in thinking about the role endothelial cells play in immune responses in cardiovascular disease – not just as gatekeepers regulating immune cell infiltration, but as active mediators of T cell phenotype and survival.
I am incredibly grateful to my PI and mentor Patrick Murphy for his guidance, patience, and unwavering support.
I am also deeply thankful for the help of my co-authors and the many hands that contributed along the way.
It was a long road – but a journey defined by challenges met with grit and determination that ultimately led to this pretty remarkable success.”
Title: Endothelial Elavl1 Is Required for CD8 T-Cell Persistence in Atherosclerosis
Authors: Sarah-Anne E Nicholas, Stephen B Helming, Antoine Ménoret, Christopher L Pathoulas, Maria M Xu, Jessica Hensel, Amy L Kimble, Brent Heineman, Evan R Jellison, Bo Reese, Beiyan Zhou, Annabelle Rodriguez-Oquendo, Anthony T Vella, Patrick A Murphy

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series